Rhythm Pharmaceuticals, Inc. (RYTM) earnings
RYTM earnings moved a median of +0.58% by the close. Quarterly and annual RYTM reports and results, each read against the price at its own news timestamp. Back to the RYTM overview →
32 measured RYTM earnings events.
Where these RYTM earnings landedvs 32 measured RYTM earnings reactions
| Middle 50% of RYTM earnings reactions | -1.84% to +2.35% |
|---|---|
| Median reaction (to close) | +0.58% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 RYTM earnings events with a measured close landed between -1.84% and +2.35%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | -1.80% | -0.11% | |
| Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update | Press release | +1.24% | +5.07% | |
| Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 | Press release | +1.03% | +2.32% | |
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +0.71% | +3.81% | |
| Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update | Press release | +3.90% | -0.20% | |
| Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026 | Press release | +0.25% | +0.98% | |
| Form 10-K RHYTHM PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.91% | -4.07% | |
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -0.08% | -3.27% | |
| Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update | Press release | +2.03% | +2.47% | |
| Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 | Press release | +0.28% | +1.37% | |
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.63% | +2.30% | |
| Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Update | Press release | -1.24% | +1.58% | |
| Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 | Press release | -0.31% | -0.01% | |
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | -1.03% | -5.08% | |
| Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update | Press release | +3.84% | +5.83% | |
| Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025 | Press release | +0.03% | -1.27% | |
| Form 10-K RHYTHM PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -0.39% | +2.98% | |
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +3.59% | +4.42% | |
| Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update | Press release | +3.59% | +4.42% | |
| Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024 | Press release | +0.72% | +0.62% | |
| Form 10-Q/A RHYTHM PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | -0.90% | -0.36% | |
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | -1.02% | -2.57% | |
| Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update | Press release | -3.12% | -4.05% | |
| Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 | Press release | +0.59% | +0.55% | |
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | -2.46% | +1.75% | |
| Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update | Press release | +2.00% | -3.70% | |
| Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 | Press release | -1.52% | -1.60% | |
| Form 10-K RHYTHM PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.81% | +2.44% | |
| Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update | Press release | -9.73% | -10.08% | |
| Form 10-Q RHYTHM PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -2.59% | -2.57% | |
| Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update | Press release | -1.51% | +1.70% | |
| Rhythm Pharmaceuticals to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023 | Press release | +0.00% | +0.36% |
Keep exploring
More RYTM: analyst actions → · SEC filings → · RYTM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Axon Enterprise, Inc. (AXON) | 478 | -0.04% | 48% |
| RXI PHARMACEUTICALS CORP (RXII) | 477 | -1.14% | 32% |
| Ascendis Pharma A/S - Ordinary Share (ASND) | 474 | -0.08% | 48% |
| Global Cord Blood Corporation (CO) | 471 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.